アレルギー治療の世界市場

アレルギー治療の世界市場は2030年までに241億米ドルに達する見込み

2023年に186億米ドルと推定されるアレルギー治療の世界市場は、2023～2030年の分析期間においてCAGR 3.8%で成長し、2030年には241億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである喘息治療は、CAGR 4.3%を記録し、分析期間終了時には59億米ドルに達すると予測されます。鼻炎治療セグメントの成長率は、分析期間中CAGR 4.6％と推定されます。

米国市場は50億米ドルと推定、中国はCAGR6.6%で成長予測

米国のアレルギー治療市場は2023年に50億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに50億米ドルの市場規模に達すると予測され、分析期間2023～2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と4.4%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

アレルギー治療-主要動向と促進要因

アレルギー治療は、世界のアレルギー疾患の有病率の上昇に対応し、現代医療においてますます不可欠なものとなっています。アレルギーは、花粉、食物、ペットのフケなどの物質に対する過敏な免疫反応であり、軽度の不快感から重篤なアナフィラキシーまで幅広い症状を引き起こし、何百万人もの人々に影響を及ぼしています。アレルギーの主要タイプには、呼吸器アレルギー（花粉症や喘息など）、食物アレルギー、皮膚アレルギー（湿疹など）、虫刺されアレルギーなどがあります。治療法はアレルギータイプと重症度によって異なり、薬剤療法、免疫療法、生活習慣の改善などがあります。抗ヒスタミン薬、副腎皮質ステロイド薬、充血除去薬、ロイコトリエン阻害薬などが症状の管理に一般的に使用され、皮下注射や舌下錠などの免疫療法は、特定のアレルゲンに対する免疫系を減感作することで長期的な緩和をもたらします。これらの治療法の有効性により、アレルギーの管理はより達成可能なものとなり、多くの患者の生活の質を向上させています。

アレルギー治療の重要な動向は、標的生物製剤の開発であり、重度のアレルギー症状を管理するためのより個別化されたアプローチを記載しています。モノクローナル抗体などの生物製剤は、アレルギー反応に関与する免疫系の成分を特異的に標的として作用します。例えば、重度の喘息や慢性蕁麻疹の治療に用いられるモノクローナル抗体であるオマリズマブは、アレルギー反応の主要な担い手である免疫グロブリンE（IgE）を標的としています。これらの先進治療は、従来の治療で十分な効果が得られない患者にとって特に有益です。さらに、アレルゲンへの曝露を最小限にするために、アレルゲン回避戦略や空気清浄機や低アレルギー性製品の使用など、非薬理学的介入が重視されるようになってきています。成分分解診断法などの診断技術の進歩により、アレルゲン感受性をより正確に同定できるようになり、オーダーメイドの治療計画が可能になりました。また、遠隔医療がアレルギー診療に統合されたことで、特に遠隔地や十分な診療を受けていない地域において、専門医による診察や継続的な管理へのアクセスが改善されました。

アレルギー治療市場の成長は、アレルギー疾患の有病率の増加、生物学的療法の進歩、アレルギー管理に対する意識の高まりなど、いくつかの要因によってもたらされます。環境汚染、ライフスタイルの変化、遺伝的素因などの要因に影響されるアレルギーの罹患率の増加は、効果的な治療に対する需要の高まりにつながっています。医薬品開発の技術的進歩により、重度のアレルギーに的を絞った緩和を提供する革新的な生物学的療法の採用が促進され、治療の選択肢が拡大しています。アレルギーの早期診断と予防的管理の重要性に対する意識の高まりは、より多くの人々が医師の診断を受け、治療レジメンを遵守するよう促しています。さらに、医療のインフラが拡大し、市販のアレルギー治療が入手可能になったことで、アレルギー治療がより身近なものになりました。また、遠隔医療やデジタルヘルスソリューションの採用が増加していることも、患者の治療へのアクセスを向上させ、治療のアドヒアランスを改善することで市場の成長に寄与しています。これらの要因が総合的にアレルギー治療市場の堅調な成長を後押しし、アレルギー疾患のより良い管理と患者の転帰の改善を確実なものにしています。

調査対象企業の例（注目の12社）

• ALK-Abello A/S
• Allergan PLC
• ALLERGOPHARMA GmbH & Co. KG
• Allergy Therapeutics plc
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Sanofi SA
• Stallergenes Greer

目次

第1章 調査手法

第2章 エグゼクティブ概要

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の展望

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他の欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他のアジア太平洋
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他のラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他の中東
• アフリカ

第4章 競合

Global Allergy Treatment Market to Reach US$24.1 Billion by 2030

The global market for Allergy Treatment estimated at US$18.6 Billion in the year 2023, is expected to reach US$24.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Asthma Treatment, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Rhinitis Treatment segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Allergy Treatment market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Allergy Treatment - Key Trends and Drivers

Allergy treatment has become increasingly essential in modern healthcare, addressing the rising prevalence of allergic conditions worldwide. Allergies, which are hypersensitive immune responses to substances such as pollen, food, or pet dander, affect millions of individuals, causing symptoms ranging from mild discomfort to severe anaphylaxis. The primary types of allergies include respiratory allergies (such as hay fever and asthma), food allergies, skin allergies (such as eczema), and insect sting allergies. Treatment options vary depending on the type and severity of the allergy and include medications, immunotherapy, and lifestyle modifications. Antihistamines, corticosteroids, decongestants, and leukotriene inhibitors are commonly used to manage symptoms, while immunotherapy, including subcutaneous injections and sublingual tablets, offers long-term relief by desensitizing the immune system to specific allergens. The effectiveness of these treatments has made managing allergies more attainable, improving the quality of life for many patients.

A significant trend in allergy treatment is the development of targeted biologic therapies, which offer a more personalized approach to managing severe allergic conditions. Biologics, such as monoclonal antibodies, work by specifically targeting components of the immune system involved in allergic reactions. For instance, omalizumab, a monoclonal antibody used in the treatment of severe asthma and chronic urticaria, targets immunoglobulin E (IgE), a key player in allergic responses. These advanced treatments are particularly beneficial for patients who do not respond adequately to traditional therapies. Additionally, there is a growing emphasis on non-pharmacological interventions, including allergen avoidance strategies and the use of air purifiers and hypoallergenic products, to minimize exposure to allergens. Advances in diagnostic techniques, such as component-resolved diagnostics, enable more precise identification of allergen sensitivities, allowing for tailored treatment plans. The integration of telemedicine in allergy care has also improved access to specialist consultations and ongoing management, particularly in remote or underserved areas.

The growth in the allergy treatment market is driven by several factors, including the increasing prevalence of allergic conditions, advancements in biologic therapies, and the rise in awareness about allergy management. The rising incidence of allergies, influenced by factors such as environmental pollution, lifestyle changes, and genetic predisposition, has led to greater demand for effective treatments. Technological advancements in drug development have facilitated the introduction of innovative biologic therapies that provide targeted relief for severe allergies, expanding treatment options. Growing awareness about the importance of early diagnosis and proactive management of allergies has prompted more individuals to seek medical advice and adhere to treatment regimens. Furthermore, the expansion of healthcare infrastructure and the availability of over-the-counter allergy medications have made allergy treatments more accessible. The increasing adoption of telemedicine and digital health solutions is also contributing to market growth by enhancing patient access to care and improving treatment adherence. These factors collectively drive the robust growth of the allergy treatment market, ensuring better management of allergic conditions and improved patient outcomes.

Select Competitors (Total 12 Featured) -

• ALK-Abello A/S
• Allergan PLC
• ALLERGOPHARMA GmbH & Co. KG
• Allergy Therapeutics plc
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Sanofi SA
• Stallergenes Greer

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Allergy Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Allergic Conditions Expands Addressable Market Opportunity for Allergy Treatments
  • Advances in Biologic Therapies Propel Growth in Allergy Treatment Options
  • Increasing Adoption of Personalized Medicine Throws the Spotlight on Tailored Allergy Treatments
  • Development of Targeted Monoclonal Antibodies Strengthens Business Case for Innovative Therapies
  • Growing Use of Non-Pharmacological Interventions Drives Adoption of Allergen Avoidance Strategies
  • Advancements in Diagnostic Techniques Propel Precision in Allergy Identification and Treatment
  • Integration of Telemedicine in Allergy Care Expands Market Reach and Enhances Access to Specialists
  • Rising Awareness about Allergy Management Generates Demand for Early Diagnosis and Treatment
  • Increasing Availability of Over-the-Counter Allergy Medications Drives Consumer Adoption
  • Influence of Environmental Pollution and Lifestyle Changes Propels Demand for Effective Allergy Treatments
  • Adoption of Digital Health Solutions and Mobile Health Apps Generates Opportunities for Enhanced Patient Care
  • Growing Emphasis on Preventive Healthcare Expands Market Potential for Allergy Treatments
  • Rising Incidence of Food Allergies Spurs Demand for Specialized Allergy Treatments
  • Advances in Air Purification Technologies Enhance Market for Allergen Avoidance Products
  • Consumer Preference for Hypoallergenic Products Drives Growth in Allergy Treatment Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Allergy Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Allergy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Skin Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Skin Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Skin Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Food Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Food Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Food Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Eye Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Eye Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Eye Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Anti-Allergy Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Anti-Allergy Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Anti-Allergy Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Intranasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Intranasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for Intranasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• JAPAN
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• CHINA
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: China 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: China 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: China 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• EUROPE
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Allergy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• FRANCE
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: France 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: France 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: France 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• GERMANY
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Allergy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• INDIA
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: India 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: India 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: India 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Allergy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Allergy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
• AFRICA
  • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030

IV. COMPETITION